The Economic and Clinical Impact of Improving Blood Collection

Recent research conducted by Becker's Hospital Review in 2023 indicates that hospital C-suites are seeking technology solutions engineered to address gaps in nurse training and hands-on experience with vital care tasks. With nurses often pressed for time at patients' bedsides, there is concern that key infection control steps may be overlooked, leading to poor practice. While nurses may be reluctant to adopt new workflows, hospital leadership recognizes the long-term cost savings and improved outcomes associated with these technologies.

With a renewed focus on costs, quality, and efficiency, hospital administrators are prioritizing innovations designed to improve bedside care and workflow. Blood collection has been identified as a common high-risk procedure needing improvement across all care settings. Revolutionizing these methods through integrated technologies can reduce complications and move key indicators in a positive direction.

Vascular Integrity’s ByPass Syringe® is an integrated blood collection device designed to improve safety, infection control, vascular access preservation, and efficiency during IV blood draws and associated procedures. It aims to reduce complications like needlestick injuries, blood exposure, catheter occlusion, and catheter-associated infections.

The ByPass Syringe is commonly used by hospitals for blood diversion, to help reduce false positive blood cultures. Pending the size of the hospital, data has shown annualized costs of $1.4-$1.8 million and added an estimated 1450-2200 extra hospital days per year(1). In addition to driving down False Positives, hospital’s also commonly leverage the ByPass Syringe for its Velocity Reduction Technology™ to help reduce hemolysis. Data has shown that hemolyzed blood samples can cost a hospital approximately $4 million per year and add an avg of 1 hour to a patient’s length of stay per event (2).

Doing more with less offers the best solution. As one product with multiple applications, The ByPass Syringe may provide a new option for high-risk blood collection in the acute care setting from all patient populations in all care areas, saving nurses time while reducing hospital costs.

References:

  1. Zwang, O. and Albert, R.K. (2006), Analysis of strategies to improve cost effectiveness of blood cultures. J. Hosp. Med., 1: 272-276. https://doi.org/10.1002/jhm.115
  2. Michael P Phelan, Christopher Ramos, Laura E Walker, Gerald Richland, Edmunds Z Reineks, The Hidden Cost of Hemolyzed Blood Samples in the Emergency Department, The Journal of Applied Laboratory Medicine, Volume 6, Issue 6, November 2021, Pages 1607–1610, https://doi.org/10.1093/jalm/jfab035

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>